DISEASE IMPACT AND COST-EFFECTIVENESS OF A NEW DENGUE VACCINE TAK003 IN THAILAND
Intro: Dengue, a vector-borne disease, is a global threat to public health with incidence increased from 0.5 to 5.2 million cases between 2010 and 2019. Data collected over ∼57 months of the phase-3 DEN-301 trial of the candidate vaccine (TAK-003) demonstrated long-term efficacy against symptomatic...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-05-01
|
| Series: | International Journal of Infectious Diseases |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1201971223004769 |